P2RY2 and graft versus host disease: The findings from multiple groups in different models of pathogenic inflammation indicate a central function of different purinergic receptors, such as P2X7 and P2Y2, in ATP-activated recipient myeloid cells during GvHD, which could be exploited when targeting danger signals to prevent GvHD.